Menu
Décideurs

De Gaulle Fleurance recognized in the Décideurs – Leaders League 2025 ranking, category: Healthcare, Pharma, and Biotechnology

Awards 5 September 2025

De Gaulle Fleurance is proud to be recognized in the Décideurs – Leaders League 2025 ranking for its expertise in Healthcare, Pharma, and Biotechnology, reflecting the commitment and excellence of our experts in supporting our clients in this area.

Regulatory law - Essential

Frédéric
Destal
Partner
Cécile
Théard-Jallu
Partner

E-health - Essential

Cécile
Théard-Jallu
Partner

Patents / Pharma, biotech, and life sciences litigation - Excellent

Louis
de Gaulle
Partner
Julien
Horn
Partner
Francine
Le Péchon-Joubert
Partner

Licensing, co-development, and R&D agreements - Excellent

Francine
Le Péchon-Joubert
Partner
Cécile
Théard-Jallu
Partner

Healthcare criminal law - Strong reputation

Albane
Lancrenon
Partner

Capital operations, joint ventures, and corporate - Strong reputation

Jean-Christophe
Amy
Partner
François
Couhadon
Partner
Mireille
Mull-Jochem
Partner

Venture capital operations - Strong reputation

Jean-Christophe
Amy
Partner
Henri-Nicolas
Fleurance
Partner

Distribution law - Strong reputation

Cécile
Théard-Jallu
Partner
Thierry
Titone
Partner
Would you like to be kept up to date with the latest news on this topic?
Sign up to receive e-mails of new articles, events, analysis... on the subjects most relevant to you.
Create your customized watch

Receive news on the topics
that matter to you


Latest news

Deals 16 July 2026
De Gaulle Fleurance is advising the Caisse des Dépôts on the restoration of the Vauban Citadel in Belle-Île-en-Mer
Van Lys Bank
Deals 8 July 2026
De Gaulle Fleurance advises Van Lys Bank, the investment bank of Caisse d’Epargne Hauts-de-France, on the financing of Spacinov’s first LBO
CIC-BNP-LCL
Deals 7 July 2026
De Gaulle Fleurance has advised the lenders on the financing of Ailancy’s acquisition of the Valmen Group
Deals 1 July 2026
De Gaulle Fleurance advises Fundcraft on its expansion into France and the acquisition of its AIFM authorization